Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves ...

Petal Surgical says its acoustic liquefaction platform uses “focused acoustic energy to break down targeted tissue without ...

A new study 1 found that the use of stereotactic body radiation therapy (SBRT) produced similar overall survival in patients ...